Insights

Strategic Growth Abcam recently became part of Danaher, signaling a strong corporate backing and potential access to larger procurement channels, cross-sell opportunities, and integrated supplier programs that could expand product adoption across their extensive research portfolio.

Broad Customer Reach With a global footprint serving 750,000 researchers in over 130 countries, there are sizable opportunities to upsell complementary reagents, diagnostic and therapeutic toolsets, and platform integrations tailored to diverse labs and regions.

Tech & Cloud Enablement Adoption of cloud and collaboration tools (Google Cloud Platform, Microsoft Azure, SharePoint, Jira, Confluence) suggests openness to software-enabled solutions, data management services, inventory automation, and digital procurement partnerships.

Recent Acquisition Momentum Danaher’s acquisition of Abcam indicates potential for enhanced scale, preferred supplier status, and involvement in enterprise-wide sourcing initiatives, presenting a pathway for strategic contracts and long-term procurement arrangements.

Key Growth Areas Focus areas such as cancer, neurological, infectious, and metabolic disorders align with opportunities to propose specialized assay solutions, high-throughput reagents, and platform-compatible tools that support current research priorities.

Similar companies to Abcam

Abcam Tech Stack

Abcam uses 8 technology products and services including HashiCorp Terraform, Microsoft SharePoint, Google Cloud Platform, and more. Explore Abcam's tech stack below.

Media & News

Abcam's Email Address Formats

Abcam uses at least 3 email formats:
Abcam Email FormatsExamplePercentage
First.Last@abcam.comJohn.Doe@abcam.com
87%
FLast@abcam.comJDoe@abcam.com
12%
First.L@abcam.comJohn.D@abcam.com
1%

Frequently Asked Questions

What is Abcam's phone number?

Minus sign iconPlus sign icon
You can contact Abcam's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abcam's stock symbol?

Minus sign iconPlus sign icon
Abcam is a publicly traded company; the company's stock symbol is ABCM.

What is Abcam's official website and social media links?

Minus sign iconPlus sign icon
Abcam's official website is abcam.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Abcam generate?

Minus sign iconPlus sign icon
As of October 2026, Abcam's annual revenue is estimated to be $1B - $10B.

What is Abcam's SIC code and NAICS code?

Minus sign iconPlus sign icon
Abcam's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abcam have currently?

Minus sign iconPlus sign icon
As of October 2026, Abcam has approximately 1.9K employees across 6 continents, including Europe, North America and Asia. Key team members include Cmo: J. B., Chief Financial Officer: M. C. and Chief Technology Officer: D. P. Explore Abcam's employee directory with LeadIQ.

What industry does Abcam belong to?

Minus sign iconPlus sign icon
Abcam operates in the Biotechnology Research industry.

What technology does Abcam use?

Minus sign iconPlus sign icon
Abcam's tech stack includes HashiCorp Terraform, Microsoft SharePoint, Google Cloud Platform, Atlassian Jira, Palo Alto Firewalls, Microsoft Azure, Adobe Creative Suite and Atlassian Confluence.

What is Abcam's email format?

Minus sign iconPlus sign icon
Abcam's email format typically follows the pattern of First.Last@abcam.com. Find more Abcam email formats with LeadIQ.

How much funding has Abcam raised to date?

Minus sign iconPlus sign icon
As of October 2026, Abcam has raised $336M in funding. The last funding round occurred on Jun 15, 2019 for $257M.
Abcam logo

Abcam

Biotechnology ResearchEngland, United Kingdom1001-5000 Employees

Abcam is a biotechnology research company headquartered on Discovery Drive in Cambridge, England. It provides biological reagents and related products and solutions to support fundamental research, drug discovery, diagnostics, and therapeutic applications. The company serves approximately 750,000 researchers in more than 130 countries, with work spanning cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam has 1,001 to 5,000 employees and operates as part of Danaher following the completion of its acquisition in December 2023. The company maintains a website at https://abcam.com.

Section iconCompany Overview

Phone number
Website
abcam.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ABCM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $336M

    Abcam has raised a total of $336M of funding over 3 rounds. Their latest funding round was raised on Jun 15, 2019 in the amount of $257M as a Post IPO Equity.

  • $1B - $10B

    Abcam's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.